Showing items 1201-1225 of 2549 (102 Page(s) Totally)
<< < 44 45 46 47 48 49 50 51 52 53 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2020-07-21T06:46:21Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin C.-C.; Lee J.-H.; Chang Y.-L.; Su K.-Y.; Hsu W.-H.; Hsu C.-L.; Tsai T.-H.; Chen K.-Y.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; CHAO-CHI HO; Liao W.-Y.; Yu C.-J.; Yang J.C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:46:19Z |
Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors
|
Liao B.-C.; Bai Y.-Y.; Lee J.-H.; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; CHAO-CHI HO; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Chih-Hsin Yang J.; Yang P.-C. |
| 臺大學術典藏 |
2020-07-21T06:46:19Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Yu C.-J.; CHAO-CHI HO; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.; Lin C.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:46:18Z |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients
|
Wu T.-H.; Hsiue E.H.-C.; Lee J.-H.; Lin C.-C.; Liao W.-Y.; CHAO-CHI HO; Shih J.-Y.; Yu C.-J.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-07-21T06:46:16Z |
Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients
|
Yao Z.-H.; Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:15Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Chang Y.-L.; Su K.-Y.; Hsu C.-L.; Liu Y.-N.; Chen K.-Y.; Tsai T.-H.; Liao W.-Y.; CHAO-CHI HO; Yang C.-Y. |
| 臺大學術典藏 |
2020-07-21T06:25:17Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Yang J.C.-H.; Thress K.S.; Huang D.D.-R.; Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tzu-Hsiu Tsai;Su K.-Y.;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; TZU-HSIU TSAI; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y. |
| 臺大學術典藏 |
2020-07-21T06:25:17Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Liao W.-Y.; Ho C.-C.; Liao B.-C.; Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tzu-Hsiu Tsai;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Yang J.C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Lee J.-H.; Chang Y.-L.; Su K.-Y.; Hsu W.-H.; Hsu C.-L.; TZU-HSIU TSAI; Chen K.-Y. |
| 臺大學術典藏 |
2020-07-21T06:09:13Z |
Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer
|
Yang J.C.-H.; Chang Y.-C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Chen K.-Y.; Ho C.-C.; WEI-YU LIAO; Yang P.-C.; Chen H.-Y.; Hsu W.-H.; Lin Y.-L.; Lee J.-H.; Lee J.-H.;Lin Y.-L.;Hsu W.-H.;Chen H.-Y.;Chang Y.-C.;Yu C.-J.;Shih J.-Y.;Lin C.-C.;Chen K.-Y.;Ho C.-C.;Wei-Yu Liao;Yang P.-C.;Yang J.C.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:09Z |
Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib
|
Yu C.-J.; Yang J.C.H.; Yao Z.-H.;Wei-Yu Liao;Ho C.-C.;Chen K.-Y.;Shih J.-Y.;Chen J.-S.;Lin Z.-Z.;Lin C.-C.;Yang J.C.H.;Yu C.-J.; Yao Z.-H.; WEI-YU LIAO; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C. |
| 臺大學術典藏 |
2020-07-21T06:09:08Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Wei-Yu Liao;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; WEI-YU LIAO; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:09:06Z |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients
|
Shih J.-Y.; Ho C.-C.; Wu T.-H.;Hsiue E.H.-C.;Lee J.-H.;Lin C.-C.;Wei-Yu Liao;Ho C.-C.;Shih J.-Y.;Yu C.-J.;Yang J.C.-H.; Wu T.-H.; Hsiue E.H.-C.; Lee J.-H.; Lin C.-C.; WEI-YU LIAO; Yu C.-J.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:03Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Chen K.-Y.; Tsai T.-H.; Ho C.-C.; WEI-YU LIAO; Yang C.-Y.; Yang C.-Y.;Wei-Yu Liao;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yu C.-J.; Yang J.C.-H.; Shih J.-Y.; Lin C.-C.; Lee J.-H.; Hsu W.-H.; Liao B.-C.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C. |
| 臺大學術典藏 |
2020-07-21T05:40:29Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Lee J.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Ching-Yao Yang;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; CHING-YAO YANG; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H. |
| 臺大學術典藏 |
2020-07-16T02:45:42Z |
GAS-HYDRATE SYSTEMS AND GAS VOLUMETRIC ASSESSMENT IN THE LOWER FANGLIAO BASIN, TAIWAN ACCRETIONARY WEDGE
|
Dirgantara, F.; Lin, A.T.-S.; Liu, C.-S.; Lin, C.-C.; Chen, S.-C. |
| 臺大學術典藏 |
2020-07-10T08:17:56Z |
Forgetting the unforgotten affective autobiographical memories in nonclinical dissociators
|
Chiu, C.-D.; Lin, C.-C.; Yeh, Y.-Y.; Hwu, H.-G.; YEI-YU YEH |
| 臺大學術典藏 |
2020-07-10T08:17:55Z |
Unintentional memory inhibition is weakened in non-clinical dissociators
|
Chiu, C.-D.;Yeh, Y.-Y.;Huang, C.-L.;Wu, Y.-C.;Chiu, Y.-C.;Lin, C.-C.; Chiu, C.-D.; Yeh, Y.-Y.; Huang, C.-L.; Wu, Y.-C.; Chiu, Y.-C.; Lin, C.-C.; YEI-YU YEH |
| 臺大學術典藏 |
2020-07-10T08:17:03Z |
Facial and prosodic emotion recognition in social anxiety disorder
|
Chen, S.-H.; SUE-HUEI CHEN; Lin, C.-C.; Liang, K.-Y.; Tseng, H.-H.;Huang, Y.-L.;Chen, J.-T.;Liang, K.-Y.;Lin, C.-C.;Chen, S.-H.; Tseng, H.-H.; Huang, Y.-L.; Chen, J.-T. |
| 臺大學術典藏 |
2020-07-05T03:15:32Z |
Loss of imprinting and overexpression of IGF2 gene in gastric adenocarcinoma
|
Wu M.-S.;Wang H.-P.;Lin C.-C.;Sheu J.-C.;Chia-Tung Shun;Lee W.-J.;Lin J.-T.; Wu M.-S.; Wang H.-P.; Lin C.-C.; Sheu J.-C.; CHIA-TUNG SHUN; Lee W.-J.; Lin J.-T. |
| 臺大學術典藏 |
2020-07-03T04:00:44Z |
Unraveling the role of the rssC gene of serratia marcescens by atomic force microscopy
|
Sheu B.-C.; Sheu B.-C.;Lin C.-C.;Fu Y.-H.;Lee S.-Y.;Hsin-Chih Lai;Wu R.-S.;Liu C.-H.;Tsai J.-C.;Lin S.; Tsai J.-C.; Lin S.; Liu C.-H.; Wu R.-S.; HSIN-CHIH LAI; Lee S.-Y.; Fu Y.-H.; Lin C.-C. |
| 臺大學術典藏 |
2020-07-03T02:18:41Z |
Genetic characterization of the rotaviruses associated with a nursery outbreak
|
Lee C.-N.;Lin C.-C.;Chuan-Liang Kao;Zao C.-L.;Shih M.-C.;Chen H.-N.; Lee C.-N.; Lin C.-C.; CHUAN-LIANG KAO; Zao C.-L.; Shih M.-C.; Chen H.-N. |
| 臺大學術典藏 |
2020-07-01T08:53:26Z |
Mercury, APOE, and child behavior
|
Ng S.;Lin C.-C.;Suh-Fang Jeng;Hwang Y.-H.;Hsieh W.-S.;Chen P.-C.; Ng S.; Lin C.-C.; SUH-FANG JENG; Hwang Y.-H.; Hsieh W.-S.; Chen P.-C. |
| 臺大學術典藏 |
2020-07-01T08:12:19Z |
ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis
|
Chiu K.-L.;Lin Y.-S.;Kuo T.-T.;Lo C.-C.;Huang Y.-K.;Chang H.-F.;Chuang E.Y.;Lin C.-C.;Cheng W.-C.;Liu Y.-N.;Liang-Chuan Lai;Sher Y.-P.; Chiu K.-L.; Lin Y.-S.; Kuo T.-T.; Lo C.-C.; Huang Y.-K.; Chang H.-F.; Chuang E.Y.; Lin C.-C.; Cheng W.-C.; Liu Y.-N.; LIANG-CHUAN LAI; Sher Y.-P. |
| 臺大學術典藏 |
2020-07-01T08:12:17Z |
ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT
|
Lin C.-Y.;Cho C.-F.;Bai S.-T.;Liu J.-P.;Kuo T.-T.;Wang L.-J.;Lin Y.-S.;Lin C.-C.;Liang-Chuan Lai;Lu T.-P.;Hsieh C.-Y.;Chu C.-N.;Cheng D.-C.;Sher Y.-P.; Lin C.-Y.; Cho C.-F.; Bai S.-T.; Liu J.-P.; Kuo T.-T.; Wang L.-J.; Lin Y.-S.; Lin C.-C.; LIANG-CHUAN LAI; Lu T.-P.; Hsieh C.-Y.; Chu C.-N.; Cheng D.-C.; Sher Y.-P. |
| 臺大學術典藏 |
2020-07-01T06:19:58Z |
Influence of age-related degeneration on regenerative potential of human nucleus pulposus cells
|
Shu-Hua Yang;Lin C.-C.;Hu M.-H.;Shih T.T.-F.;Sun Y.-H.;Lin F.-H.; SHU-HUA YANG; Lin C.-C.; Hu M.-H.; Shih T.T.-F.; Sun Y.-H.; Lin F.-H. |
Showing items 1201-1225 of 2549 (102 Page(s) Totally)
<< < 44 45 46 47 48 49 50 51 52 53 > >>
View [10|25|50] records per page
